Eyenovia, Inc.

Eyenovia, Inc. company information, Employees & Contact Information

Explore related pages

Eyenovia, Inc. email format Eyenovia, Inc. management contacts

Related company profiles:

Eyenovia, Inc. (NASDAQ: EYEN), is an ophthalmic technology company developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications.

Company Details

Employees
22
Founded
-
Address
295 Madison Ave,
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
http://eyenovia.com
Keywords
Ophthalmology, optometry, presbyopia, technology, innovation, mydriasis, manufacturing, pharmaceutical, glaucoma, dry eye, healthcare, myopia, disruptive, lifestyle.
HQ
New York, New York
Competitors
Tarsus Pharmaceuticals, Inc., Orasis Pharmaceuticals, Laxxon Medical, Lexeo Therapeutics, Kingdom Supercultures, Protara Therapeutics, OnCusp Therapeutics, Ocular Therapeutix, Inc., BioSpherix, LLC, Delcath Systems.
Looking for a particular Eyenovia, Inc. employee's phone or email?

Eyenovia, Inc. Questions

News

Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewswire

Eyenovia Provides Development Update on Optejet User Filled Device (UFD) GlobeNewswire

Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation - Stock Titan

Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation Stock Titan

Eyenovia, Inc. Approves 1-for-80 Reverse Stock Split to Regain Nasdaq Compliance - Quiver Quantitative

Eyenovia, Inc. Approves 1-for-80 Reverse Stock Split to Regain Nasdaq Compliance Quiver Quantitative

Eyenovia Provides Update on Restructuring Efforts - Yahoo Finance

Eyenovia Provides Update on Restructuring Efforts Yahoo Finance

Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal - Stock Titan

Eyenovia Slashes Cash Burn 70% While Racing Toward Major FDA Filing and Merger Deal Stock Titan

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq GlobeNewswire

Eyenovia, Inc. Engages Chardan to Explore Strategic Alternatives for Optejet Development | EYEN Stock News - Quiver Quantitative

Eyenovia, Inc. Engages Chardan to Explore Strategic Alternatives for Optejet Development | EYEN Stock News Quiver Quantitative

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - Yahoo Finance

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering Yahoo Finance

Eyenovia Expands Its US Manufacturing Capabilities - Newswire.com

Eyenovia Expands Its US Manufacturing Capabilities Newswire.com

Eyenovia, Inc. Provides Merger Update with Betaliq and Financial Results for Q1 2025 - Nasdaq

Eyenovia, Inc. Provides Merger Update with Betaliq and Financial Results for Q1 2025 Nasdaq

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States - PR Newswire

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States PR Newswire

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - Stock Titan

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery Stock Titan

Eyenovia, Inc. Announces Discontinuation of CHAPERONE Study After Efficacy Endpoint Not Met - Quiver Quantitative

Eyenovia, Inc. Announces Discontinuation of CHAPERONE Study After Efficacy Endpoint Not Met Quiver Quantitative

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewswire

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device GlobeNewswire

Major Shake-up at Eyenovia: Massive 80:1 Share Consolidation Coming February - Stock Titan

Major Shake-up at Eyenovia: Massive 80:1 Share Consolidation Coming February Stock Titan

Eyenovia Announces Closing of $50 Million Private - GlobeNewswire

Eyenovia Announces Closing of $50 Million Private GlobeNewswire

Eyenovia Provides Updates on Potential Merger with Betaliq - GlobeNewswire

Eyenovia Provides Updates on Potential Merger with Betaliq GlobeNewswire

Eyenovia, Betaliq enter potential reverse merger agreement - Optometry Times

Eyenovia, Betaliq enter potential reverse merger agreement Optometry Times

First US Public Company Builds $45M Crypto Treasury: Eyenovia Adds Another $10M in HYPE Tokens - Stock Titan

First US Public Company Builds $45M Crypto Treasury: Eyenovia Adds Another $10M in HYPE Tokens Stock Titan

Eyenovia, Inc. Advances Development of User-Filled Optejet Device for Enhanced Ophthalmic Treatment - Nasdaq

Eyenovia, Inc. Advances Development of User-Filled Optejet Device for Enhanced Ophthalmic Treatment Nasdaq

Eyenovia Announces $50 Million Investment to Launch a - GlobeNewswire

Eyenovia Announces $50 Million Investment to Launch a GlobeNewswire

Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire

Eyenovia Announces Leading Proxy Advisory Firms, ISS and GlobeNewswire

Eyenovia Makes Bold Crypto Move: $50M Raise Powers 1M HYPE Token Buy While FDA Device Advances - Stock Titan

Eyenovia Makes Bold Crypto Move: $50M Raise Powers 1M HYPE Token Buy While FDA Device Advances Stock Titan

Eyenovia Announces Appointment of a Strategic Advisor for - GlobeNewswire

Eyenovia Announces Appointment of a Strategic Advisor for GlobeNewswire

Eyenovia Secures Major Win: 33% Lower Interest Rate and Top Crypto Advisor Join Forces - Stock Titan

Eyenovia Secures Major Win: 33% Lower Interest Rate and Top Crypto Advisor Join Forces Stock Titan

Eyenovia Announces Co-Branded Validator with Kinetiq - GlobeNewswire

Eyenovia Announces Co-Branded Validator with Kinetiq GlobeNewswire

Eyenovia Makes History: First US Public Company to Launch Institutional Crypto Validator on Hyperliquid - Stock Titan

Eyenovia Makes History: First US Public Company to Launch Institutional Crypto Validator on Hyperliquid Stock Titan

Medical Device Company Makes Historic $50M Pivot to Crypto, Becomes First HYPE Token Validator on Nasdaq - Stock Titan

Medical Device Company Makes Historic $50M Pivot to Crypto, Becomes First HYPE Token Validator on Nasdaq Stock Titan

Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology - Newswire.com

Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology Newswire.com

Eyenovia to Present Data on Preservative-Free Microbial Integrity of the Optejet® - Stock Titan

Eyenovia to Present Data on Preservative-Free Microbial Integrity of the Optejet® Stock Titan

Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First - Yahoo Finance

Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First Yahoo Finance

Eyenovia Announces Closing of Public Offering - GlobeNewswire

Eyenovia Announces Closing of Public Offering GlobeNewswire

Eyenovia Chairman Dr. Sean Ianchulev: The Making Of An iDoctor - Immigrant, Innovator, Inventor - Newswire.com

Eyenovia Chairman Dr. Sean Ianchulev: The Making Of An iDoctor - Immigrant, Innovator, Inventor Newswire.com

FDA Approves Fixed-Dose Ophthalmic Spray for Mydriasis - HCPLive

FDA Approves Fixed-Dose Ophthalmic Spray for Mydriasis HCPLive

Eyenovia Appoints Michael Rowe as Chief Executive Officer - citybiz

Eyenovia Appoints Michael Rowe as Chief Executive Officer citybiz

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations - Yahoo Finance

Eyenovia Provides Manufacturing Update and Announces Appointment of Bren Kern as SVP of Manufacturing and Operations Yahoo Finance

Eyenovia's Novel Optejet Dispenser Puts People's Eyes First - VisionMonday.com

Eyenovia's Novel Optejet Dispenser Puts People's Eyes First VisionMonday.com

Eyenovia and Arctic Vision Announce Exclusive Collaboration - GlobeNewswire

Eyenovia and Arctic Vision Announce Exclusive Collaboration GlobeNewswire

NDA Submitted for MydCombi, a Novel Mydriatic Agent - Medical Professionals Reference

NDA Submitted for MydCombi, a Novel Mydriatic Agent Medical Professionals Reference

Eyenovia’s $50 Million HYPE Treasury Strategy Is A Bold Bet On DeFi’s Future - Tekedia

Eyenovia’s $50 Million HYPE Treasury Strategy Is A Bold Bet On DeFi’s Future Tekedia

Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million - MarketScreener

Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million MarketScreener

Nasdaq-listed firm announces $50M Hyperliquid reserve — will HYPE rise further? - Crypto News

Nasdaq-listed firm announces $50M Hyperliquid reserve — will HYPE rise further? Crypto News

Companies like Eyenovia, Inc.

Protara Therapeutics logo - Similar company to Eyenovia, Inc.

Protara Therapeutics

47
OnCusp Therapeutics logo - Similar company to Eyenovia, Inc.

Oncusp Therapeutics

22
Kingdom Supercultures logo - Similar company to Eyenovia, Inc.

Kingdom Supercultures

23
Tarsus Pharmaceuticals, Inc. logo - Similar company to Eyenovia, Inc.

Tarsus Pharmaceutica...

367
Laxxon Medical logo - Similar company to Eyenovia, Inc.

Laxxon Medical

18
Ocular Therapeutix, Inc. logo - Similar company to Eyenovia, Inc.

Ocular Therapeutix, ...

308
Lexeo Therapeutics logo - Similar company to Eyenovia, Inc.

Lexeo Therapeutics

82
Delcath Systems logo - Similar company to Eyenovia, Inc.

Delcath Systems

111
Orasis Pharmaceuticals logo - Similar company to Eyenovia, Inc.

Orasis Pharmaceuticals

85
BioSpherix, LLC logo - Similar company to Eyenovia, Inc.

Biospherix, Llc

36

Top Eyenovia, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant